US 9097713
Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus
granted A61KA61K2039/505A61P
Quick answer
US patent 9097713 (Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus) held by THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC
- Grant date
- Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/14, A61P37/04